Quercetin and metabolic syndrome: A review.
Azar HosseiniBiBi Marjan RazaviMaciej BanachMahboobeh Ghasemzadeh RahbardarPublished in: Phytotherapy research : PTR (2021)
Metabolic syndrome (MetS) is a complex of diseases that lead to mortality due to the development of cardiovascular problems. Quercetin, as an important flavonoid, has various properties such as decreasing blood pressure, anti-hyperlipidemia, anti-hyperglycemia, anti-oxidant, antiviral, anticancer, anti-inflammatory, anti-microbial, neuroprotective, and cardio-protective effects. In this review article, we collected original articles from different sources such as Google Scholar, Medline, Scopus, and Pubmed, which is related to the effect of quercetin on the improvement of the signs of MetS, including elevated glucose level, hyperlipidemia, obesity, and blood pressure. According to these data, quercetin may also have a role in the management of metabolic disorders via different mechanisms such as increasing adiponectin, decreasing leptin, anti-oxidant activity, reduction of insulin resistance, the elevation of insulin level, and blocking of calcium channel. We have attempted to make some recommendations on the quercetin application in patients. However, it needs to do further clinical trials and more investigations to show the real clinical value of quercetin on metabolic syndrome.
Keyphrases
- metabolic syndrome
- insulin resistance
- blood pressure
- high fat diet
- anti inflammatory
- type diabetes
- clinical trial
- high fat diet induced
- uric acid
- adipose tissue
- end stage renal disease
- cardiovascular risk factors
- physical activity
- chronic kidney disease
- mental health
- ejection fraction
- cardiovascular events
- skeletal muscle
- cardiovascular disease
- body mass index
- glycemic control
- hypertensive patients
- clinical practice
- blood glucose
- peritoneal dialysis
- subarachnoid hemorrhage
- patient reported